Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton

By sjmartinez • June 28, 2023

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna J, Rozengurt E. Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton. Am J Physiol Gastrointest Liver Physiol. 2023 Jun 27. doi: 10.1152/ajpgi.00089.2023. Epub ahead of print. PMID: 37366601.

Tags: chemoprevention, Digestive Diseases, Hepatocellular carcinoma, Publications, Statins, Veterans Administration, YAP

Related Posts

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System

Bahdi F, Bachu VS, Aldzhyan V, Villanueva GP, Liang S, Manandhar A, Tripathi PV, Connolly LS, Ghassemi K, Issa D, Muthusamy VR. The Impact of[...]

A protocol for the Teen Bugs study: An integrative, multi-omics approach to understanding the role of the gut microbiome and mesocorticolimbic system in adolescent mental health following early adverse caregiving

Flores GD, Damon ZF, Ford M, Gancz NN, Savoca PW, Esfand SM, Chu KA, Querdasi FR, McCann CF, Westman JG, Labus JS, Clewett D, Parr[...]

Integration of the serum metabolome and gut microbiome underscores the importance of altered lipid metabolism and potential immune modulation in Parkinson’s Disease

Zhang K, Paul KC, Jacobs JP, Lin Y, Kwon D, Nianogo R, Bronstein JM, Keener AM, Yu Y, Folle AD, Jones DP, Ritz B. Integration[...]